Assessment by Time-Kill Methodology of the Synergistic Effects of Oritavancin in Combination with Other Antimicrobial Agents against Staphylococcus aureus

Oritavancin is a semisynthetic lipoglycopeptide in clinical development for serious gram-positive infections. This study describes the synergistic activity of oritavancin in combination with gentamicin, linezolid, moxifloxacin, or rifampin in time-kill studies against methicillin-susceptible, vancom...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Belley, Adam, Neesham-Grenon, Eve, Arhin, Francis F., McKay, Geoffrey A., Parr, Thomas R., Moeck, Gregory
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology (ASM) 2008
Materias:
Susceptibility
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2565878/
https://ncbi.nlm.nih.gov/pubmed/18644953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00361-08
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares